Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC has intensified enforcement against counterfeit drugs and regulatory non-compliance, including blacklisting a manufacturer, while also issuing guidance on medical device reporting and promoting public health initiatives. Businesses in the pharmaceutical and medical device sectors must strengthen their compliance and supply chain integrity to avoid penalties and protect public health.
Pharmaceuticals
Medical Devices
Food and Beverages
Export/Import
Healthcare
NAFDAC joins the Federal Ministry of Health and Social Welfare, nutrition partners, and the global community in celebrating World Breastfeeding Week 2026
NAFDAC
NAFDAC is participating in World Breastfeeding Week 2026, emphasizing the importance of breastfeeding for infant health and nutrition.
May lead to increased awareness campaigns and potential future regulations supporting breastfeeding-friendly practices in food and healthcare sectors.
Handling Manufacturer Investigation Reports for Medical Devices and IVDs
NAFDAC
NAFDAC provides guidance on handling Manufacturer Investigation Reports (MIRs) for medical devices and IVDs to ensure timely and effective response to quality issues.
Medical device and IVD manufacturers and importers must establish robust procedures for MIR handling to maintain compliance and avoid regulatory action.
Blacklisting of Onifam Laboratories Ltd
NAFDAC
NAFDAC has blacklisted Onifam Laboratories Ltd and associated entities from pharmaceutical business activities due to regulatory misrepresentation and improper use of approvals.
Businesses dealing with Onifam Laboratories must review their supply chains; the blacklisting signals stricter enforcement and the need for due diligence on partners.
Public Alert No. 037/2026 – Alert on Suspected Counterfeit Pulmicort® (Budesonide) Inhalation Suspension
NAFDAC
NAFDAC alerts the public to suspected counterfeit Pulmicort® (Budesonide) inhalation suspension in the market, urging vigilance and reporting.
Pharmacies and distributors must verify product authenticity and report suspicious products; increased scrutiny on supply chains for respiratory medicines.
Public Alert No. 036/2026 – Alert on Suspected Counterfeit Products Mimicking Forxiga® (Dapagliflozin)
NAFDAC
NAFDAC alerts the public to suspected counterfeit Forxiga® (dapagliflozin) products, emphasizing the need for authentication.
Healthcare providers and retailers must ensure they source genuine products; potential for increased inspections and penalties for counterfeit distribution.
SON rides on e-platform to facilitate international trade - Business News Nigeria
Other
SON is leveraging an electronic platform to streamline international trade processes.
Businesses involved in import/export should expect more digitalized procedures, potentially reducing delays but requiring compliance with new e-platform requirements.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide - within nigeria
Other
Guidance on registering fish farms with NEPC for export purposes, highlighting the process and benefits.
Fish farmers and exporters must register with NEPC to access export opportunities; non-compliance may limit market access.
Heightened enforcement against counterfeit drugs and regulatory violations.
Increased focus on medical device safety and reporting.
Digitalization of trade processes by SON and NEPC.
Need for robust supply chain due diligence to avoid blacklisted entities.
Opportunities in export markets for compliant businesses.
1
Review and strengthen internal procedures for handling product complaints and adverse events, especially for medical devices.
2
Verify the authenticity of pharmaceutical products and ensure sourcing from authorized distributors.
3
Conduct due diligence on business partners to avoid association with blacklisted entities.
4
Stay updated with NAFDAC alerts and public notices to promptly remove counterfeit products from shelves.
5
Register with relevant agencies (e.g., NEPC for exporters) and adopt e-platforms for trade documentation.
6
Train staff on regulatory compliance and reporting obligations.